Apixaban 5 mg is an oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It is prescribed to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). By selectively inhibiting Factor Xa, Apixaban prevents the formation of thrombin and reduces the risk of clot formation without significantly affecting platelet function. This medication is often preferred over traditional anticoagulants like warfarin due to its predictable effect, minimal food interactions, and no routine monitoring requirements in most patients.
